Company Overview of Edge Therapeutics, Inc.
Edge Therapeutics, Inc., a hospital-focused biopharmaceutical company, designs and develops implantable technology for direct delivery of therapeutic compounds to the site of brain injury. Its drugs cover therapeutic areas, such as spontaneous brain hemorrhage, traumatic brain injuries, and brain surgeries. The company develops NimoGel and NimoVent to prevent delayed cerebral ischemia, a catastrophic delayed complication after subarachnoid hemorrhage. Its therapeutics are delivered to patients in the United States and internationally. The company was founded in 2009 and is based in New Providence, New Jersey.
139 South Street
New Providence, NJ 07974
Founded in 2009
Key Executives for Edge Therapeutics, Inc.
Edge Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Avanzar Medical, Inc.||United States|
|Pall Life Sciences Puerto Rico, LLC||United States|
|Stiefel Laboratories, Inc.||United States|
|Antigen Express, Inc.||United States|
|OrgSyn Laboratory, Inc.||United States|
Recent Private Companies Transactions
March 18, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Fredericksburg, VA | AstellasPosted: Mar 07
- Princeton, NJ | RGPPosted: Mar 05
- Deerfield, IL | Takeda Pharmaceuticals North AmericaPosted: Feb 22
- San Francisco, CA | PwCPosted: Apr 12
Sponsored Financial Commentaries
To contact Edge Therapeutics, Inc., please visit www.edgetherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.